BENQ MEDICAL TECHNOLOGY CORPORATION Financials BenQ Medical Technology Corporation
Equities
4116
TW0004116009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.5 TWD | +0.54% |
|
+0.73% | -13.28% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,241 | 1,658 | 1,624 | 1,480 | 2,852 | 2,852 |
| Enterprise Value (EV) 1 | 1,118 | 1,603 | 1,585 | 1,552 | 2,870 | 3,270 |
| P/E ratio | 18.7 x | 22.1 x | 26.2 x | 51.3 x | 15.9 x | 25 x |
| Yield | 4.85% | 3.63% | 2.74% | 1.51% | 3.28% | 3.13% |
| Capitalization / Revenue | 1.01 x | 1.2 x | 1.16 x | 1.01 x | 0.97 x | 0.63 x |
| EV / Revenue | 0.91 x | 1.16 x | 1.13 x | 1.06 x | 0.97 x | 0.72 x |
| EV / EBITDA | 8.29 x | 9.94 x | 10.9 x | 14.4 x | 8.98 x | 6.15 x |
| EV / FCF | 17.2 x | 12.8 x | 17.9 x | 21.8 x | 12.7 x | 14.6 x |
| FCF Yield | 5.83% | 7.81% | 5.58% | 4.58% | 7.88% | 6.86% |
| Price to Book | 1.2 x | 1.58 x | 1.54 x | 1.43 x | 2.38 x | 2.59 x |
| Nbr of stocks (in thousands) | 44,566 | 44,566 | 44,566 | 44,566 | 44,566 | 44,566 |
| Reference price 2 | 27.85 | 37.20 | 36.45 | 33.20 | 64.00 | 64.00 |
| Announcement Date | 3/22/19 | 3/13/20 | 3/12/21 | 5/17/22 | 3/3/23 | 3/5/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,233 | 1,380 | 1,401 | 1,465 | 2,951 | 4,543 |
| EBITDA 1 | 134.8 | 161.3 | 146 | 107.7 | 319.7 | 532.2 |
| EBIT 1 | 93.56 | 118.8 | 97.21 | 46.46 | 180.2 | 365.4 |
| Operating Margin | 7.59% | 8.61% | 6.94% | 3.17% | 6.1% | 8.04% |
| Earnings before Tax (EBT) 1 | 96.16 | 119.3 | 105.7 | 61.78 | 274.9 | 310.2 |
| Net income 1 | 66.68 | 75.41 | 62.05 | 28.84 | 180.2 | 114.6 |
| Net margin | 5.41% | 5.46% | 4.43% | 1.97% | 6.11% | 2.52% |
| EPS 2 | 1.490 | 1.680 | 1.390 | 0.6471 | 4.020 | 2.560 |
| Free Cash Flow 1 | 65.1 | 125.2 | 88.52 | 71.13 | 226.2 | 224.2 |
| FCF margin | 5.28% | 9.07% | 6.32% | 4.86% | 7.66% | 4.94% |
| FCF Conversion (EBITDA) | 48.28% | 77.63% | 60.62% | 66.03% | 70.75% | 42.13% |
| FCF Conversion (Net income) | 97.63% | 166.02% | 142.65% | 246.63% | 125.48% | 195.67% |
| Dividend per Share 2 | 1.350 | 1.350 | 1.000 | 0.5000 | 2.100 | 2.000 |
| Announcement Date | 3/22/19 | 3/13/20 | 3/12/21 | 5/17/22 | 3/3/23 | 3/5/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 72.6 | 17.7 | 418 |
| Net Cash position 1 | 124 | 55.1 | 39.3 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 0.6736 x | 0.0554 x | 0.7858 x |
| Free Cash Flow 1 | 65.1 | 125 | 88.5 | 71.1 | 226 | 224 |
| ROE (net income / shareholders' equity) | 7.2% | 8.79% | 7.57% | 4.42% | 16.7% | 8.44% |
| ROA (Net income/ Total Assets) | 3.63% | 4.4% | 3.49% | 1.55% | 4.21% | 4.86% |
| Assets 1 | 1,839 | 1,712 | 1,780 | 1,862 | 4,285 | 2,359 |
| Book Value Per Share 2 | 23.30 | 23.60 | 23.70 | 23.30 | 26.90 | 24.70 |
| Cash Flow per Share 2 | 7.130 | 5.440 | 5.720 | 8.300 | 14.50 | 18.60 |
| Capex 1 | 31.4 | 18.6 | 36.4 | 30.3 | 57.1 | 133 |
| Capex / Sales | 2.54% | 1.35% | 2.6% | 2.07% | 1.94% | 2.94% |
| Announcement Date | 3/22/19 | 3/13/20 | 3/12/21 | 5/17/22 | 3/3/23 | 3/5/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -13.28% | 75.82M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +5.15% | 1.13B | |
| +13.51% | 1.12B |
- Stock Market
- Equities
- 4116 Stock
- Financials BenQ Medical Technology Corporation
